For the quarter ending 2025-12-31, SRJN had -$1,300K decrease in cash & cash equivalents over the period. -$121,800K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 95,000 |
| Depreciation and amortization | 81,400 |
| Deferred income taxes and investment tax credits | 21,900 |
| Accounts receivable | 280,500 |
| Inventories | -23,000 |
| Regulatory assets and liabilities | -17,900 |
| Accounts payable | 92,000 |
| Delayed/advance customer billings, net | -14,100 |
| Taxes accrued | -45,300 |
| Other assets and liabilities | -86,700 |
| Other | 3,000 |
| Net cash provided by operating activities | 81,000 |
| Capital expenditures | 202,800 |
| Other | -1,500 |
| Net cash used in investing activities | -201,300 |
| Issuance of long-term debt, net | 1,100,000 |
| Repayment of long-term debt | 7,500 |
| (repayment) issuance of short-term debt | -905,000 |
| Issuance of common stock | 300 |
| Dividends paid on common stock | 47,200 |
| Dividends paid on preferred stock | 3,700 |
| Debt issuance costs | 12,700 |
| Other | -5,200 |
| Net cash provided by financing activities | 119,000 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | -1,300 |
| Cash and cash equivalents at beginning of period | 41,200 |
| Cash and cash equivalents at end of period | 39,900 |
SPIRE INC (SRJN)
SPIRE INC (SRJN)